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INTRODUCTION
“The study of disease is really the study of man and 
his environment”
  
-Park 
Diarrhoea is a universal human experience. Diarrhoea is a symptom, not a 
disease in itself and it therefore may occur in a wide variety of conditions. In 
developing countries it is most commonly due to infectious cause22.
Acute infectious diarrhoea is one of the major causes of mortality in children, 
particularly in developing countries33. Diarrhoeal disorders account for a large 
proportion (18%) of childhood deaths, with estimated 1.8 million deaths per year 
globally (World Health Organization 1999)110. Also diarrhoeal illnesses may have a 
significant impact on psychomotor and cognitive development in young children. The 
WHO suspects that there are more than 700 million episodes of diarrhoea annually in 
children less than 5 years of age in developing countries. Mortality due to diarrhoea 
was approximately 3.3 million annually in the 1980s (World Health Organization 
2006)111. Currently, diarrhoea has been reported to account for 1.6-2.5 million deaths 
annually 77.  
 Persistently high  rates  of  diarrhoea among young children  despite 
intensive efforts at control are of particular concern (WHO 2006).105 Infectious 
agents are mainly bacterial,  viral,  protozoal, and rarely fungal.  Escherichia 
coli  (E.coli) is one of the important causes of enteric infections. These are 
members of the Enterobacteriaceae family, which are facultative anaerobic 
gram-negative bacilli,  which usually ferment lactose. Most faecal  E.coli are 
non-pathogens. However six major groups of diarrhoeagenic E.coli have been 
characterized  on  the  basis  of  clinical,  biochemical  and  molecular  genetic 
criteria:  1.  Entero toxigenic E.coli  (ETEC); 2.  Enteroinvasive E.coli (EIEC); 
3.EnteropathogenicE.coli (EPEC); 4.Shiga-toxin  producing E.coli (STEC)/ 
Enterohaemorrhagic E.coli (EHEC);  5.Enteroaggregative E.coli (EAEC); 
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6.Diffusely adherent E.coli (DAEC).68
Enteroinvasive Escherichia coli (EIEC) and all four species of Shigella 
are  capable  of  causing  bacillary  dysentery.  It  is  a  major  health  problem 
throughout the developing world that contributes significantly to the loss of 4.6 
million  lives  each  year  due  to  diarrhoeal  diseases.  Bacteriological 
identification  of  E.coli in  stool  or  environmental  specimens requires  48-72 
hours; further identification of EIEC entails the additional use of an expensive 
and time consuming animal assay for virulence60.  
Though molecular  methods are sensitive and rapid,  they are highly 
expensive and need considerable expertise which is not available in many 
laboratories in our country.  
Therefore  in  conjunction  with  oral  rehydration  therapy,  the 
development  of  a  simple,  inexpensive  and  reliable  method  for  the  early 
diagnosis of EIEC would reduce the duration and severity of diarrhoea and 
dysentery  by  early  institution  of  antibiotic  therapy.  Indiscriminate  use  of 
antibiotics  can  also  be  avoided,  since  it  leads  to  the  development  of 
antimicrobial  resistance.  This  study  describes  the  newly  developed 
colorimetric assay that will be useful for specific and early detection of EIEC 
and Shigella species using readily available indigenous component reagents 
and equipments.
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REVIEW OF LITERATURE
Diarrhoea is defined as the passage of loose, liquid or watery stools. 
Liquid  stools  are  passed more  than three  times a  day and it  is  a  recent 
change in consistency and character of the stool rather than the number of 
stools  that  is  more  important  (WHO  1985)109.  Dysentery  is  defined  as 
diarrhoea associated with blood and leukocytes in the stool103.      
Diarrhoea may be further classified as ‘acute’ if it lasts for less than 2 
weeks, ‘persistent’ if the duration of diarrhoea is 2-4 weeks and ‘chronic’ if 
more than 4 weeks duration84.
Acute diarrhoea may be due to following reasons41
1. Infectious                              90 %
2. Drug induced 
3. Ingestion of toxins                10 %
4. Ischemia
5. Other conditions 
    
Infectious diarrhoea may be caused by viruses, bacteria and protozoa. 
These agents of diarrhoea are acquired by ingestion of contaminated food or 
water and transmitted by faeco-oral route105.
The bacterial agents of diarrhoea can be classified into 2 groups41.
i) Invasive micro organisms and 
ii) Non invasive or Toxin producing organisms
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 INVASIVE NONINVASIVE
Enteroinvasive E.coli [EIEC]
Salmonella 
Shigella
Campylobacter
Enterohaemorrhagic E.coli [EHEC]
Yersinia enterocolitica
Yersinia pseudo tuberculosis
Vibrio parahaemolyticus
Edwardsiella tarda
Plesiomonas shigelloides
Enterotoxigenic E. coli [ETEC]
Enteropathogenic E.coli [EPEC]
Vibrio cholera O1 and non O1
Clostridium perfringens type A
Staphylococcus aureus
Bacillus cereus
Clostridium difficile
Shigella dysenteriae type 1
Enteroaggregative E.coli [EAEC]
      
          Enteroinvasive E.coli constitutes one of the important  causes of 
invasive diarrhoea in tropical regions, particularly where sanitation facilities 
are limited68.
GENUS DEFINITION:
Escherichia coli (E.coli) is member of Enterobacteriaceae family. E.coli 
is  gram negative,  non-spore forming bacilli  that  grow both aerobically and 
anaerobically  on  ordinary  laboratory  media.  It  is  oxidase  negative  and 
catalase positive; ferments glucose with production of acid or acid and gas; 
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reduces nitrates to nitrites and is motile with peritrichous flagella105. 
E.coli is methyl-red positive and ferments mannitol and mannose. It is 
generally  urease  negative,  does  not  utilize  citrate.  It  neither  produces 
hydrogen sulphide in triple sugar iron agar nor grows in potassium cyanide 
(KCN) medium. Enteroinvasive E.coli is  very similar  to  Shigella species in 
clinical,  pathological  features  and  bio-chemical  reactions.  It  resembles 
Shigella in that most strains are lysine decarboxylase negative, non-motile, 
late-lactose or non-lactose fermentors and anaerogenic59.
  HISTORICAL REVIEW 
Escherichia  coli was  first  identified  by  Theodor  Escherich,  German 
pediatrician while studying on the intestinal flora of infants. He described the 
organism in 1885 as bacterium coli commune and established its pathogenic 
properties  in  extra  intestinal  infection.  The  first  identification  of  E.coli that 
could  cause diarrhoea  was  made in  the  United  Kingdom on the  basis  of 
epidemiological  investigations  of  outbreaks  of  community  acquired  and 
nosocomial infantile gastroenteritis in 1945.  E.coli has been studied to such 
an extent that it is now the most thoroughly understood free-living live form on 
earth105.
EIEC strains were first shown to be capable of causing diarrhoea in 
volunteer studies conducted by DuPont et al. in 1971. EIEC are very similar to 
Shigella species in every respect except for their lower acid resistance which 
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results in higher infectious inoculums approximately 108 bacteria/ ml and their 
inability to produce shiga toxin which may be related to the fact that so far no 
complications  such  as  Hemolytic  Uremic  Syndrome  (HUS)  have  been 
observed in EIEC infections23. These ‘atypical’ E.coli strains had earlier been 
grouped under the ‘Alkalescens-Dispar Group’.
Compelling  evidence  indicates  that  Shigella  species  and  EIEC  are 
derived from multiple  origins  of  E.  coli and form a  single  pathovar.  EIEC 
strains are regarded as precursors of 'full-blown' Shigella evolved from E. coli. 
By gain and loss of functions, Shigella and EIEC became successful human 
pathogens through convergent evolution from diverse genomic background79.
       
 HABITAT
E.coli is part of the normal intestinal flora of both humans and warm-
blooded animals. The organism is excreted in faeces and may survive in the 
environment;  however,  it  appears  that  there  is  no  independent  existence 
outside the body. Thus E.coli is considered an indicator organism for faecal 
contamination and is an important parameter in food and water hygiene. The 
organisms are transmitted by faeco-oral route or via contaminated food and 
water105.
CLASSIFICATION OF ENTEROVIRULENT E.COLI 
Based on the Clinical, biochemical, molecular characteristics and their 
pattern  of  interaction  with  epithelial  cells  and  tissue  culture  monolayer, 
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diarrhoeagenic E.coli is classified as71
1. Enterotoxigenic E.coli (ETEC)
2. Enteropathogenic E.coli (EPEC)
3. Enterohaemorrhagic E.coli (EHEC)
4. Enteroinvasive E.coli (EIEC)
5. Enteroaggregative E.coli (EAEC) and 
6. Diffusely Adherent E.coli (DAEC) 68
In addition to the 6 classes of diarrhoeagenic E.coli mentioned above, 
there are other potential classes, such as ‘’cytolethal distending toxin (CDT) 
producing  E.coli and cell detaching  E.coli (CDEC) that have yet to be fully 
characterized68.
MORPHOLOGY
 E.coli is a rod shaped cell of 2-6 µm in length and 1.1-1.5 µm in width 
with rounded ends75.  The shape may vary from coccal to long filamentous 
rods43.  By  Gram’s  stain,  it  appears  as  gram-negative  rods  with  uniform 
staining. It does not form spores. It is usually motile by peritrichous flagella, 
except the “inactive” biovar of  E.coli57,  99.  It possesses a capsule made of 
acidic  polysaccharide74.  It  produces different  kinds of  fimbriae that  vary in 
structure and antigenic specificities74.
METABOLISM AND GROWTH REQUIREMENT
E.coli is  an  aerobic,  facultative  anaerobic  organism.  It  is  a  chemo-
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organotroph, having both respiratory and fermentative type of metabolism, but 
the  growth  is  less  copious  under  anaerobic  conditions.  E.coli exerts 
pronounced  metabolic  activity  between  15˚C  and  45˚C43;  under  optimum 
conditions the generation time is 20 minutes. 
The optimum temperature is 37˚C at which they grow well on ordinary 
media containing 1% peptone44. In contrast to most other coliform bacteria, 
E.coli ferments  lactose  and  produces  indole  at  44˚C  that  is  used  for 
identification in food and water bacteriology. E.coli is more heat resistant than 
most  other  species  of  Enterobacteriaceae  and  survives  at  60  ˚C  for  15 
minutes or 55 ˚C for 60 minutes. It is sensitive to brilliant green and 0.25% 
deoxycholate43.
Escherichia strains  can  be  maintained  for  years  in  tightly  closed 
nutrient  agar  stabs  or  on  Dorset  egg  medium  kept  in  the  dark  at  room 
temperature. However, even without further subcultures such strains tend to 
mutate  to  the  R  forms  and  to  lose  virulence  plasmids.  Cultures  can  be 
preserved in tryptic soy broth containing 20-40 % glycerol at -70˚C or in liquid 
nitrogen74.
 STRUCTURAL FEATURES 
Inner membrane
The inner or cytoplasmic membrane, which is impermeable to polar 
molecules, regulates the passage of nutrients, metabolites, macromolecules 
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and information in and out of the cytoplasm and maintains the proton motive 
force required for energy storage61. 
Periplasmic space
A  variety  of  functional  categories  of  proteins  are  found  in  the 
periplasm73 including  an  Apyrase  enzyme  –  a  novel  variant  of  acid 
phosphatase.50
Peptidoglycan cell wall
It is composed of a thin layer of Peptidoglycan, with a short peptide 
and D-alanine attached to the carboxyl group of muramic acid. The envelope 
is responsible for the shape and osmotic stability of the organism78.
Outer membrane
 The outer membrane is an asymmetrical lipid bilayer. Phospholipids 
occur  almost  exclusively  in  the  inner  layer;  whereas  the  outer  layer  is 
composed of peptidoglycan. It plays a major role in protecting the bacteria 
from various detergents, dyes and hydrophobic antibiotics72. 
Lipopolysaccharide (LPS)
The LPS is an extremely potent virulence factor of EIEC. The common 
serogroups of EIEC have LPS antigens related to the Shigella LPS. It has 
three  major  domains,  the  lipid  backbone,  the  core  phosphorylated 
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oligosaccharide, and the repeating oligosaccharide side chains. Lipid A, also 
known as endotoxin, is the biologically active portion of the molecule that is 
recognized by the host. The repeating oligosaccharide attached to the LPS 
core is known as O antigen and is the basis for serogroup classification82. 
SURFACE ANTIGENS
The  surface  antigens  consists  of  the  following  were  useful  in 
serotyping of E.coli.
 Somatic antigen (O antigen)
There are 173 O groups in E.coli. As E.coli O antigens are not type or 
species  specific,  numerous  cross  reactions  are  known  between  E.coli  & 
Shigella, Citrobacter, Salmonella, Providencia and Yersinia 43.   Therefore O-
antigen  typing  must  always  be  associated  with  a  proper  biochemical 
identification  of  isolates43.  This  is  particularly  important  for  Shigellae that 
share partial or identical O antigens with E.coli. The following table shows the 
example of identical O antigens in EIEC and Shigellae71. 
Antigenic sharing with Shigella
EIEC –O antigen Shigella -corresponding O serovar
O 112 ac O2 S.dysenteriae
O124  O3  S. dysenteriae
O152  O12  S.dysenteriae
O143  O8  S.boydii
Capsule (K antigen)
These antigens are belonging to  class I  capsular  polysaccharides48. 
Capsules widely vary in chemical structure and are the basis of the K-antigen 
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serotyping scheme. There is over 100 K-antigen types in E.coli.
Fimbria (F antigen)
 Certain fimbrial  antigens are involved in the adhesion process and 
therefore are important virulence factors.  They develop at  37˚C but  not at 
18 ˚C. They are heat labile proteins. Fimbrial antigens agglutinate a variety of 
erythrocytes that can be used for their characterization75. 
 Flagella (H antigens)
There  are  56  H-antigens  available  in  E.coli.  They  serve  several 
functions,  including  roles  in  adhesion  and  genetic  exchange  through 
conjugation29. 
EPIDEMIOLOGY OF ENTEROINVASIVE E.COLI
         Epidemiologic studies of EIEC mostly describe outbreaks. In sporadic 
cases, many EIEC strains are probably misidentified as  Shigella species or 
nonpathogenic  E. coli  strains. It affects all the age groups, but children are 
more  susceptible.  Since  EIEC  has  got  higher  environmental  resistance,52 
EIEC outbreaks are usually food borne or waterborne56, 63,100.although person-
to-person transmission does occur40. The infective dose of EIEC in volunteers 
is  higher  than that  for  Shigella  species24,  thus the potential  for  person-to-
person  transmission  is  lessened.  Endemic  disease  occurs  in  developing 
countries, where these bacteria can be isolated with relatively high frequency. 
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Endemicity occurs generally where  Shigella species are also prevalent, but 
the epidemiologic features may be different from those of Shigella species52. 
In the developing world, as many as 5% of sporadic diarrhoea and 20% of 
bloody diarrhoea cases may be caused by EIEC strains68.The incidence of 
EIEC in developed countries is thought to be low, but occasional food borne 
outbreaks, do occur80.
VIRULENCE FACTORS 
Though E.coli is a commensal intestinal flora, it is considered as one of 
the primary enteric pathogens. Pathogenic strains posses special virulence 
factors  that  are  usually  absent  in  commensal  E.coli.  There  is  general 
conceptual agreement on the principle of “Molecular Koch’s postulates” as 
articulated by Stanley Falkow. By this definition “a trait is considered to be 
virulence factor if  it is found specifically in strains of a microbe that cause 
disease”.  Adhesins,  enterotoxins,  hemolysin,  iron  acquisition, 
lipopolysaccharide, capsule and plasmids are some of the virulence factors of 
E.coli 61.
    a) Secretion systems and toxins
EIEC can directly interact with host cell  through a dedicated type III 
secretion system (T3SS). They not only export proteins through the inner and 
outer bacterial membranes, but also inject them into or through the host cell 
membrane35.
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b) Iron acquisition
Iron is an essential element, required by virtually all-living organisms 
as a cofactor for several indispensable enzymes. Enterobacterial pathogens 
contain several efficient systems that scavenge iron. Siderophores are low 
molecular-weight iron chelating molecules that are synthesized, secreted and 
recaptured by microorganisms. Siderophores are mainly of 2 types
1. The phenolate type e.g. enterobactin
2. Hydroxamate type e.g. aerobactin
 Aerobactin is considered to be an important virulence factor for EIEC101.  
c) Plasmids
Enteroinvasion  of  EIEC  is  mediated  by  a  220  mega  Dalton  high-
molecular-weight  plasmid  81.  The genes encoded on plasmids may play a 
major role in pathogenesis. The entire Type III secretion system that endows 
Enteroinvasive E.coli and Shigella strains with the ability to invade epithelial 
cells is encoded by mxi and spa genes present on a large plasmid2, 3,108. 
d) Apyrase
Apyrase  (ATP-diphosphohydrolase)  enzyme  is  found  in  eukaryotes 
and some prokaryotes. In prokaryotes, Apyrase has been found only in EIEC 
and Shigellae 94.       
Apyrase is a Periplasmic enzyme, present only in virulent strains of 
EIEC and Shigella 53. It is encoded by phoN2 (apy) gene present in a large 
virulence plasmid and also in the chromosome. Expression of phoN2 (apy) is 
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regulated  by  the  virF-virB gene  cascade91.  It  has  been  considered  as  a 
potential virulence factor for the following reasons94, 92. 
• Apyrase is involved in the process of mitochondrial damage resulting in 
      death of the EIEC infected host cell.
• Recently it has been shown to be involved in intracellular spread of the 
pathogen.  The ability  of  EIEC to  move  within  the  cytoplasm of  the 
infected  cells  and  to  spread  to  adjacent  cells  solely  relies  on  the 
production and localization of Ics A protein at one pole of the bacterial 
surface. The apyrase is responsible for this unipolar localization of Ics 
A protein92. 
• It also plays a major role in inducing condensation of the host actin to 
form an actin tail by Ics A protein, there by allows EIEC to propel itself 
through the cytoplasm of infected cells to adjacent cells92.
The  following  Virulence  genes  are  responsible  for  pathogenesis  of  EIEC 
infection 105.
Virulence 
Genes Location Putative role of gene product in disease
ipa D p
Attachment to host cell, induces rearrangement of cytoskeleton 
and phagocytosis
ipa B ,ipa C p
Induction of phagocytosis , lysis of phagosome after which cells 
reach the cytoplasm
Mxi p At least 10 different loci; involved in export of Ipa proteins
Ics A, ics B p Intercellular spread between adjacent cells
vir F p Transcriptional activator of vir B
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vir B p
Transcriptional activator of ipa gene family (ipa A, ipa B,
ipa C, ipa D), regulate the expression of phoN2 gene which 
codes for the Apyrase enzyme92.
Vir R c
Negative regulator of vir F ; probably mediates temperature 
control of virulence expression
vac C ,vac B, 
ksp A
c Regulate ipa gene family and ics A
Omp R ,
env Z
c Osmoregulation of virulence genes located on plasmids
Ipa H, ial p Used as a target genes for PCR
c- Chromosome p- Plasmid
                 EIEC PATHOGENESIS
         
          Courtesy: A.R. Pavankumar and K. Sankaran: Tools for surveillance of                
          Escherichia coli, Food Technol. Biotechnol. 46 (2)125–145 (2008) 129. 
PATHOGENESIS AND PATHOLOGY
EIEC  enters  the  phagocytic  ‘M’  cells  (micro  fold  cells),  which  are 
15
specialized epithelial cells overlying mucosal lymphoid follicles, and are taken 
up by macrophages  90.  However,  they  escape the phagosome and trigger 
apoptosis of the macrophage and are released. They enter adjacent cells by 
binding to host protein called integrins9, 46, located at the basolateral surface 
and thereby invoking phagocytic uptake by these cells88. Meanwhile, these 
events trigger the host inflammatory response, attracting polymorphonuclear 
cells that migrate to the luminal side, destroying tight junctions between the 
epithelial cells.  Once EIEC enters the host cell; a complex array of proteins 
induces condensation of host actin to form actin tail by the protein IcsA 1, 107, 
which allows EIEC to propel itself through the cytoplasm to adjacent cell9, 36. 
They replicate therein, resulting in necrosis and stripping of large areas of 
colonic mucosa and dysentery similar to but usually less severe than Shigella 
dysentery 18, 42. The inflammation decreases colonic reabsorption resulting in 
diarrhoea4.  EIEC  causes  colonic  lesions  with  ulcerations,  hemorrhage, 
mucosal  and  sub  mucosal  edema  with  infiltration  by  polymorphonuclear 
leukocytes71. 
The  expression  of  invasiveness  is  complex.  The  invasion  related 
plasmid  has  been  designated  as  pInV 6,  where  the  genes  required  for 
bacterial  entry  into  epithelial  cells  are  clustered.  Prominent  among  these 
genes are the  mxi and spa loci, which encode a so-called type III secretion 
apparatus. This machinery is required for the secretion of multiple proteins 
which are necessary for full pathogenicity. Among these proteins, the invasion 
plasmid antigens Ipa A, B, C & D are necessary for invasion 65. Other proteins 
16
including the enzyme apyrase play a role in the ability of EIEC to move within 
the cytoplasm of infected cells and to spread to other cells66.The ipa H and ial 
genes were used as a target for PCR to detect EIEC from stool samples.71
CLINICAL FEATURES    
Infection  usually  is  confined  to  the  gastrointestinal  mucosa83.  The 
ability  of  EIEC  to  invade  and  colonize  the  intestinal  epithelium  is  a  key 
determinant  of  the  disease.  Infection  presents  most  commonly  as  acute 
watery diarrhoea, indistinguishable from ETEC68. It progresses to dysentery 
characterized by severe cramps, fever, tenesmus, frequent passage of small 
volume of stool with mucus and blood103. It affects all the age groups. Their 
inability  to  produce  shigatoxin  may  be  related  to  the  fact  that  so  far  no 
complications such as Hemolytic  Uremic Syndrom have been observed in 
EIEC infections106.
TYPING METHODS 
There  are  numerous  methods  available  for  sub  typing  E.coli.  Each 
method  has  advantages  and  disadvantages  when  applied  to  a  specific 
situation.
            1. Conventional typing methods
 Biotyping19 
 Resistotyping105
 Serotyping75 
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            2. Molecular methods
 Plasmid profile12 
 Restriction endonuclease digestion and gel electrophoresis105 
 DNA hybridization-Southern blot analysis and  colony blots of bacterial 
cultures39
 Randomly amplified polymorphic DNA14
 Pulsed field gel electrophoresis67
Biotyping is the most widely used typing method to characterize E.coli. 
Ornithine decarboxylase, Lysine, Mucus, Motility and gas production can be 
used for initial detection of EIEC strains32, 103. Resistotyping may provide a first 
hint for a common origin of 2 or more strains. 
Conventional typing methods have been succeeded in recent years by 
molecular techniques that are applicable to a wide variety of organisms with 
only minimal adaptation in the procedures. These newer methods are often 
more discriminatory but technically more demanding and require specialized 
equipments.
SEROLOGICAL ANALYSIS
Serotyping of E.  coli occupies a central  role in  the history of  these 
pathogens. Prior to the identification of specific virulence factors, serotyping 
was the predominant method by which this organism was identified in the 
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laboratory. In 1944, Kauffman proposed a scheme which classified E.coli, the 
modified form of which is still in use today.
E.coli comprises of  many serotypes.  A combinations of  O (cell  wall 
polysaccharide),  H  (flagellar  proteins),  K  (capsular  polysaccharide  or 
envelope) antigens, which are identified with antisera raised against 173 O 
antigens,  56  H  antigens  and  more  than  100  K  antigens.  A  specific 
combination of O and H antigens defines the serotype of an isolate. The most 
common serotypes associated with  Enteroinvasive E.coli are O28ac,  O29, 
O112ac, O124, O136, O143, O144, O152 and O164.51 
LABORATORY DIAGNOSIS
COLLECTION AND TRANSPORT OF THE FECAL SPECIMENS:
The stool  specimens should be collected in a  clean,  wide mouthed 
container covered with a tight fitting lid. Rectal  swabs may be collected in 
newborn and severely debilitated adults. The samples should be transported 
immediately to the laboratory; if a delay longer than 2 hours is anticipated the 
specimen should be placed in a transport medium. Glycerol phosphate buffer 
supports viability of EIEC better than other media54.
CULTURE CHARACTERISTICS 
Enteroinvasive E.coli strains grow well in ordinary media containing 1% 
peptone.  The  use  of  Xylose  Lysine  Deoxycholate  in  combination  with 
macConkey  or  Eosine  Methylene  Blue  agar  provides  the  best  chance  of 
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recovery of EIEC from faecal samples102.  5-10 suspicious colonies may be 
selected for definitive biochemical reactions, combined with agglutination with 
group or serovar specific antisera.
Nutrient agar:
 After  18-24  hrs  of  incubation,  large  (2-3mm),  circular,  glistening, 
smooth, convex and non-pigmented colonies are produced by smooth forms 
whereas rough form produces dry, wrinkled, rough colonies105.
MacConkey agar
Colonies  are  pink  lactose  fermenting  or  non-lactose  fermenting 
colonies as in the case of atypical biovar105, 54.
Xylose-Lysine Deoxycholate agar
Yellow  or  translucent  colonies  without  black  center  (Hydrogen 
sulphide) are produced105.
Liquid media                        
In  liquid  media  such  as  peptone  water,  smooth  forms  show 
homogenous  turbid  growth  after  12-18  hours,  whereas  rough  forms 
agglutinate  spontaneously,  forming  a  sediment  on  the  bottom  of  the  test 
tubes. Pellicle formation on the surface of liquid media can be seen in heavily 
fimbriated strains after prolonged incubation for more than 72 hrs at 37˚C105. 
      
Biochemical Characteristics
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The following table shows the differentiating biochemical features of 
E.coli and Shigella
+,  ≥90%  positive;  -,  ≤10%  positive;  v-  variable,  11-89%  positive;  +a  -  Shigella 
dysentriae always negative31.
Tests for confirmation
             EIEC strains are confirmed by the following tests for invasiveness. 
                                                                           
a. Sereny’s test
The  test  assesses  the  ability  of  EIEC  to  cause  an  ulcerative 
keratoconjunctivitis after instillation onto the cornea of a guinea pig/rabbit95. 
The animal is examined daily for the development of keratoconjuncivitis for 7 
days.  There is cell  destruction and superficial inflammatory invasion of the 
cornea similar to that in colonic mucosa. The disadvantage of the test is the 
cost  of  animal;  painful  technique  and  objections  often  made  on  humane 
grounds61.
b. Tissue culture test
       Tissue culture study is done to detect the ability of EIEC strains to invade 
intestinal epithelial cells. The invasive phenotype of the bacterial isolates is 
confirmed  by  invasiveness  in  a  confluent  monolayer  of  HeLa  cells/  Hep2 
21
cells67.  Hep2  monolayer  is  overlaid  with  2ml  of  the  bacterial  suspension 
containing  107  organisms/ml.  After  incubation  at  37°C  for  two  and  a  half 
hours,  the  monolayer  is  washed,  fixed  and  stained  with  Giemsa.  The 
monolayer  is  examined  under  oil  immersion  by  light  microscope  for  the 
presence of intracellular organisms and plaque formation. Tissue culture test 
is a better alternative to the sereny test as it gives more detailed study of the 
invasive mechanism20.
c. Congo red binding assay
Congo red binding (CRB) capacities are encoded by 220 kb virulence 
plasmid; hence virulence property of EIEC is well correlated with CRB76. The 
virulent strains can be identified by the appearance of red colonies on Congo 
red dye agar60.
d. Virulence marker antigen (VMA) ELISA
The  plasmid  codes  for  outer  membrane  antigens  called  Virulence 
marker antigen can be detected by the ELISA test16, 60. 
e. Colorimetric assay
The simple test detects the enzyme Apyrase, which is specific for EIEC and Shigella. 
The test uses sodium pyrophosphate as a substrate for the enzyme. EDTA used in the test 
acts as a buffer and a metal chelator to suppress other phophatase and pyrophophatase 
activities that  are present  in the stool.  The released monophosphate can be detected by 
adding ammonium molybdate and ferrous ammonium sulfate,  with  which it  react  to  form 
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molybdenum blue. This results in a change of color to blue. This can also be read with a 
spectrophotometer to find out the optical density value55. The test can not differentiate EIEC 
and Shigella. However, for clinical laboratories, determining the presence of virulence factors 
will be more meaningful than genus level identification105.
This  test  detects  the  Apyrase  enzyme  in  8  hours.  Less  technical 
expertise is required for this test, when compared to the methods currently 
available for the diagnosis of EIEC. Moreover, multiple samples can be tested 
simultaneously  and  results  can  be  interpreted  by  using  color  card  or 
colorimeter. Hence it can be used during epidemics of EIEC infection where 
large  numbers  of  cases  have  to  be  screened,  where  the  expensive 
equipments  cannot  be  accessed.  It  assists  in  the  early  institution  of 
antimicrobial therapy, as the results can be obtained on the same day.55
Apyrase is being chosen as a diagnostic target because5,55 
 It is specific to EIEC and Shigella
 It can be assayed by a simple and sensitive colorimetric method
 Its surface accessibility minimizes sample handling and processing
 Its ability to act both on organic and inorganic pyrophosphates in 
the  absence  of  metal  ions  makes  it  possible  to  detect  it  in  the 
presence  of  other  cellular  phosphates  and  pyrophosphates, 
which invariably require metal ions5.
f. Polymerase chain reaction for EIEC
PCR involves the enzymatic amplification of DNA in vitro. This method 
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is capable of increasing the amount of the target DNA sequence in a sample 
by synthesizing many copies of DNA segment. PCR is carried out in discrete 
cycles and each cycle of amplification can double the amount of target DNA. 
The target DNA is exponentially amplified so that after ‘n’ cycles there are 2n 
times as much target DNA as was present initially.
PCR targeting virulence associated gene sequences can be performed 
on colony sweeps from MacConkey agar or other moderately selective agar 
plates.  Ideally  such  a  procedure  should  be  followed  by  subculture  and 
identification of the responsible pathogenic strain105.
Direct PCR with stool samples has also been developed, which targets 
invasion plasmid antigen H (ipaH) gene sequences. This PCR system is very 
effective for diagnosing cases of dysentery. Direct PCR on stool samples help 
in rapid diagnosis; but it could not differentiate EIEC from Shigella97.
 PCR using ial probe is virtually 100% sensitive and specific for EIEC 
strains that have retained their virulence87. The ial PCR is also effective in a 
multiplex  PCR  system  to  identify  EIEC  strains  simultaneously  with  other 
E. coli categories.  phoN2 (apy) genes present on 220MDa large virulence 
plasmid can also be used as a target for PCR50. 
                  ANTIMICROBIAL RESISTANCE
The expression of one or more antibiotic resistances by the majority of 
the EIEC strains raises the potential for problems when treating diarrhoea 
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and dysentery produced by EIEC39. 
 EXTENDED SPECTRUM β-LACTAMASE PRODUCTION
The  treatment  of  E.coli infection  is  increasingly  becoming  difficult 
because of the multi drug resistance exhibited by the organisms. ESBLs are 
increasingly found in E.coli. These are plasmid mediated β-lactamases which 
have the ability to hydrolyze β-lactam antibiotic containing oxyimino group. 
ESBLs  have  serine  at  their  active  site  and attack  the  amide bond in  the 
lactum ring of antibiotics causing their hydrolysis15.
 
ESBLs can be detected by the following tests15 
1. Double disc synergy test
2. Three dimensional test
3. Inhibitor potential disc diffusion test
4. Disc approximation test
5. MIC reduction test
6. E test
7. Molecular methods
TREATMENT
         The broad principles of management of acute gastroenteritis in children 
include  oral  rehydration  therapy,  enteral  feeding  and  diet  selection,  Zinc 
supplementation and additional therapies such as probiotics. Early diagnosis 
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and timely antibiotic therapy in EIEC infection may shorten the duration of 
illness  and  prevents  complications.  Trimethoprime-sulfamethoxazole  is  an 
appropriate choice of antibiotic if the organisms are susceptible71.
PREVENTION
Preventive strategies includes
1. Promotion of exclusive breast feeding
2. Improved complimentary feeding practices like Vitamin A supplementation reduces 
childhood diarrhoea by 34%.
3. Improved  water  and  sanitary  facilities  and  promotion  of  personal  and  domestic 
hygeine.
4. Behavioural change strategies through hand washing promotion and access to soap 
reduce the burden of diarrhoea in developing countries71. 
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AIMS OF THE STUDY
• To study the incidence of Enteroinvasive Escherichia coli infection in 
children with diarrhoea and dysentery
• To evaluate colorimetric  assay for  Apyrase enzyme as a diagnostic 
tool in the early diagnosis of EIEC diarrhoea
• To compare colorimetric assay with Polymerase Chain Reaction and 
Sereny’s test
• To determine the serotype of the EIEC isolates
• To determine the antimicrobial susceptibility pattern of the isolates
• To  estimate  the  prevalence  of  Extended  spectrum  β-lactamase 
production among the EIEC isolates
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MATERIALS AND METHODS
 PERIOD OF STUDY: 
 December 2006 to May 2008.
PLACE OF STUDY: 
This  cross  sectional  study  was  conducted  at  the  Institute  of 
Microbiology,  Sample were collected from Institute  of  Child health Madras 
Medical College and Government General Hospital, Chennai-3.
SELECTION OF STUDY GROUP87
A total of 145 children, 0-5 years of age were included in the study. 
The  patients  were  clinically  examined  and  selected  for  the  study  after 
obtaining the history.
Inclusion criteria
Children were included in the study if they had more than three loose 
stools in 24 hours or an episode of dysentery.
Exclusion criteria
  The following children were excluded from the study
1. Children with diarrhoea due to food intolerance
 2. The children who acquired diarrhoeal illness after hospital admission.
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SELECTION OF CONTROL GROUP:
A total of 50 children with no history of diarrhea for a period of 2 weeks 
in the 0-5 years of age were included for comparison with the study group. 
ETHICAL CONSIDERATION
Ethical  and  research  clearance  was  obtained  from  the 
Institutional  Ethical  Committee,  Government  General  Hospital  &  Madras 
Medical  College,  Chennai-3.  Permission  to  conduct  the  study was sought 
from the respective hospital authorities. Informed consent was obtained from 
parents/ guardians of the child before enrolment into the study.
STATISTICAL ANALYSIS
The  proportional  data  of  cross  sectional  study  was  tested  using 
Pearson’s  Chi-square(x2)  analysis,  Two  sample  binomial  proportion  test. 
Statistical  analyses  were  carried  out  using  Statistical  Package  for  Social 
Sciences (SPSS) and Epi-info software.
COLLECTION AND TRANSPORT OF STOOL SAMPLES
The stool samples were collected in a clean wide mouthed container 
transported to the laboratory and processed within one hour54. The usage of 
any transport  media  was  avoided as  the  phosphate  buffer  present  in  the 
media might alter the results of colorimetric assay.
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MICROBIOLOGICAL ANALYSIS
Macroscopic examination:
 The stool samples were examined for color, consistency, presence of 
blood, mucus, segments of parasite and foreign body.
Direct microscopic examination:
Saline,  Iodine  and  Methylene  blue  stained  wet  preparations  were 
examined for the presence of erythrocytes, leukocytes, ova and cysts of the 
parasites. 
Isolation and Identification of EIEC
The  collected  stool  samples,  if  present,  mucus  or  blood  stained 
portions  were  inoculated  onto  MacConkey  agar  agar,  Xylose  Lysine 
Deoxycholate agar102 and SeleniteF broth. The plates were incubated at 37˚C 
for 24 hours. The selenite F broth was sub-cultured onto XLD agar after 6-8 
hours of incubation and these plates were read after overnight incubation. On 
XLD agar: EIEC produced yellow or pink colonies without black center54. On 
MacConkey agar agar: EIEC colonies appeared as either lactose fermenting 
or non lactose fermenting; hence from each sample the lactose positive and 
all  lactose negative colonies were subjected to identification procedures103. 
Similar  to  study group,  the  stool  samples  from control  children  were  also 
processed by standard microbiological procedures.
30
The following tests were used for identification of E.coli
1. Catalase
2.  Oxidase
3. Indole
4. Triple Sugar Iron agar
5. Citrate
6. Urease
7. Mannitol motility medium
The  stool  samples  collected  from  study  and  control  group  were 
subjected  to  colorimetric  assay  to  detect  the  presence  of  the  enzyme 
Apyrase. The Apyrase positive isolates and E.coli isolates were retested with 
colorimetric assay after 7 hours of culture in Luria Bertani broth and were 
subjected  to  PCR  also.  Then  PCR  positive  strains  were  tested  for  their 
invasiveness by Sereny’s test. The isolates were preserved in Nutrient broth 
containing 40% glycerol frozen at -70˚C39.
All the isolates were subsequently tested for antimicrobial susceptibility 
by Kirby-Bauer disc diffusion method with a battery of 7 different antibiotics. 
ESBL producers were detected by combined test method. 
Sereny’s test:
          A volume of 25µL containing 109organisms/ml was put into the right 
conjunctival sac of test animal. A 25µL of culture containing 109organisms/ml 
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of Shigella dysenteriae was given to the control animal, which served as the 
positive control.  The uninoculated left  eye of each animal used in the test 
served the negative control. Animals were examined daily for 7 days for the 
evidence of conjunctivitis or keratoconjunctivitis20.   
Serotyping: 
The isolates were sent to Centre for Diarrhoeal Diseases Research & 
Training, Kolkata for serotyping.
ANTIMICROBIAL RESISTANCE
Antimicrobial susceptibility pattern 7
 Mueller-Hinton agar plate was inoculated with 0.5 McFarland standard 
inoculums to obtain a lawn culture. Using sterile forceps, discs were placed 
over the agar surface,  incubated at  37˚C for overnight.   The results  were 
interpreted as per Clinical Laboratory Standards Institute (CLSI) standards. 
The E.coli strain ATCC 25922 was included as a quality control in all tests.
 The following antibiotic discs were used17:
Drug
Disc 
content 
(μg)
Diameter of zone of 
inhibition (mm)
R I S
ATCC 
E.coli
25922
 Amikacin 30 14 15-16 17 19-26
 Ampicillin 10 13 14-16 17 16-22
 Cefoperazone-Sulbactum 75 15 16-20 21 28-34
 Cefotaxime 30 14 15-22 23 29-35
 Ciprofloxacin 5 15 16-20 21 30-40
 Co-trimoxazole T1.25/S23.75 10 15-Nov 16 23-29
 Gentamicin 10 12 13-14 15 19-26
                                                                              CLSI Vol26 No.1, Jan. 2006
R: Resistant ; I: Intermediate; S: Sensitive
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Extended Spectrum β-lactamase detection17
A two step screening and confirmation of ESBL was done.
Step 1- Screening
 Cefotaxime and  Ceftazidime were  used  as  an  indicator  drugs.  The 
isolates showing resistance to Cefotaxime (≤22mm) and Ceftazidime (≤18) 
were considered as suspected ESBL producers69. 
                  
Step 2- Confirmatory test:
Combined disc method:
Mueller-Hinton agar plate was inoculated with 0.5 McFarland standard 
inoculums  to  obtain  a  lawn  culture.  The  discs  of  ceftazidime  (30µg)  and 
ceftazidime-clavulanic  acid  (30/10 µg)  were  kept  over  agar  surface.  An 
increase  of  5  mm  or  more  in  diameter  of  the  zone  of  inhibition  with 
ceftazidime-clavulanic  acid  when  compared  to  ceftazidime  alone  was 
confirmed an ESBL producer69, 15.
COLORIMETRIC ASSAY
All the steps were performed using transparent radioimmunoassay (RIA) vials. The 
positive  test  results  in  a  change  of  color  to  blue.  This  can  also  be  read  with  a 
spectrophotometer to find out the optical density (OD) value and can also estimate the color 
semi quantitatively against a color card. The OD value of 0.3 was taken as cut-off point. The 
Apyrase gene,  apy of  Shigella was cloned in vector plasmid pRSETB and maintained in 
E.coli strains GJ1158 was used as a positive control and Enteropathogenic E.coli was used 
as a negative control5, 55. 
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Materials
1. Centrifuge
2. Vortex
3. Spectrophotometer
4. Reagents
    i. Wash Reagent: 0.9% Saline- 1mM Calcium chloride
   ii. Assay Reagent 
        a) Assay buffer: 40mM EDTA, pH 7.5
        b) Substrate Solution: 6mM Sodium Pyrophosphate
  iii. Color Reagent
                  a) Reagent A: 5% Acidic Ammonium Molybdate
              b) Reagent B: 1% Ferrous Ammonium Sulphate
a. Treatment of stool samples for detection of EIEC
This following procedure is done for the benefit of simplified inoculation 
and to minimize pyrophosphatases contamination from stool particles. These 
insoluble  stool  materials  are  retained  by  the  filter  paper  whereas  the 
organisms pass through and inoculate the media in the vials.
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Take Radioimmunoassay (RIA) vials with cap, with 1 ml of Luria Bertani 
medium.
Pierce the bottom of the caps at four different places with the help of a 25G 
needle
Place the Whatmann NO.1 filter paper snugly against perforated bottom of 
the caps
Add 500µl of stool samples into the cap
Seal the caps with a piece of parafilm “M”
Spin the RIA vials at 4000 rpm, for 1 minute, to inoculate the media contained 
in the vial
The vials are incubated at 37˚C for 7 hours
Then do the assay for the presence of Apyrase.
b. Diagnostic assay protocol for apyrase
Culture grown for 7 hours at 37˚C
Pellet down at 6000 rpm for 3 minutes
Discard the supernatant, add 1 ml of wash reagent and suspend           
the pellet by brief and gentle vortexing
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2 times
Pellet down at 6000 rpm for 3 minutes
Add 300 µl of assay Reagent and suspend by brief vortexing
Incubate at 37˚C for 15 minutes
Spin at 6000 rpm for 3 minutes and remove 100 µl of supernatant from each 
sample and transfer to a microtitre plate
Add 200 µl of color Reagent and leave at room temperature for 10 minutes
Read at 650 nm
POLYMERASE CHAIN REACTION 50, 55
PREPARATION OF CELL LYSATE
Cell lysates of isolates were used as DNA templates for colony lysate 
PCR. Around 5-10 colonies were suspended in 100  µl of Tris-EDTA buffer 
and boiled for 5 minutes and rapidly chilled on ice for 5 minutes. After 4 min of 
centrifugation  in  a  microfuge  at  12,000  rpm,  1µl  of  the  supernatant  was 
obtained and used as template. 
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COMPONENTS OF PCR:
1. Oligonucleotides
The  oligonucleotides  used  in  this  procedure  were  only  24  nucleotides  in 
length because they were too short to form stable hybrids at the temperature 
used for polymerization. Oligonucleotides were used at a concentration of 5 
pico moles were sufficient for 30 cycles of amplification.
Oligonucleotides used in this protocol are:
Forward primer--apy-1, 5’GGG AAT TCC ATA TGA AAA CCA AAA A 3’
Reverse primer--apy-4, 5’CCC AAG CTT TTA TGG GGT CAG TTC ATT 3’
2. PCR Buffer
DNAs used as templates were dissolved in low ionic Tris- EDTA buffer. 
The concentration of Mg²+ optimized when ever a new combination of target 
and primer was used and also when deoxynucleotide triphosphate (d NTP) 
primers were altered.
3. Taq DNA polymerase
A  genetically  engineered  form  of  enzyme  synthesized  in  E.coli 
(Amplitaq) was used. This polymerase enzyme carries a 3’ to 5’ exonuclease 
activity.  Approximately 2 units  of  this enzyme were required to catalyze a 
typical PCR.
4. Deoxynucleotide triphosphate (dNTPs)
Deoxynucleotide  Triphosphate  (dNTP’s)  is  used  at  saturating 
concentration (200µl of each dNTP’s). A stock solution of dNTP’s (50mM) is 
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adjusted to pH7 with 1N NaOH to ensure that the pH of the final reaction does 
not fall below pH7.
PCR REACTION MIXTURE
PCR PROTOCOL
Amplification was carried out in  eppendorf  gradient thermal cycler for 
35  cycles  with  initial  denaturation  of  DNA  for  5  minutes  at  95˚C,  then 
subsequently for 1 minute at 95˚C for each cycle. Annealing of the primer was 
done for 1 minute at 55˚C and elongation of chain for 1 minute at 72˚C. After 
the completion of 35 cycles, a warming up period of 7 minutes was given.
 
 The same composition of PCR mixture was used for all PCR reactions. 
Native apyrase clone and Enteropathogenic E.coli were used as a positive 
and negative control respectively. The PCR amplification products were run in 
horizontal 1.2% agarose gel electrophoresis, which was set at 125 V and run 
for 1 hour. The gel was visualized using a UV transilluminator. PCR products 
and 100 base pair molecular markers were seen as bright fluorescent adducts 
due to binding adduction of ethidium bromide to DNA.
INTERPRETATION
In positive amplification, a single PCR product band at 790 base pair 
was obtained.
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RESULTS
• 195 stool samples were collected from children less than 5 years of 
age which include 145 children with diarrhoea and 50 controls without 
diarrhoea.  The  samples  were  cultured  for  Escherichia  coli,  and 
identified  by  standard  microbiological  procedures  such  as  colony 
morphology, relevant bio-chemical reactions and serotype. 
• The new Colorimetric assay was done for all stool samples to detect 
the specific enzyme Apyrase. The colorimetric assay was repeated for 
141 isolates, which include 138  E.coli strains and 3 other organisms 
that showed positivity in colorimetric assay. 
• PCR was carried out for 141 isolates to detect apy gene.
• The  PCR  positive  Enteroinvasive  Escherichia  Coli strains  were 
confirmed by sereny test.
• The results of these tests are as follows:
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Table-1
AGE AND GENDER DISTRIBUTION OF STUDY AND CONTROL GROUP
In  the study group,  the male to  female ratio  was 1:0.9 and among 
control children the ratio was 1:1.
Table-2
ORGANISMS IDENTIFIED IN STOOL SAMPLES (n=195)
Study group (n=145) Control group (n=50)
Two sample 
Binomial 
proportion 
test
No. of 
samples
Bacterial 
isolates
Protozoa 
observed under 
microscope
No. of 
samples
Bacterial 
isolates
Protozoa 
observed 
under 
microscope
145 166         16 50 74           7
Total 182 Total 81
z=3.06
p=0.002
Significant
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Table-3
TYPE OF ORGANISMS ISOLATED/ VIEWED BY MICROSCOPY FROM
 DIARRHOEAL STOOL SAMPLE  (n=263)
Nature of the 
isolate Organism
Study group Control group
No. of 
the 
isolates
%
No. of 
the 
isolates
%
Bacteria
(by culture)
Escherichia coli 138 75.82 45 55.55
Klebsiella species 22 12.08 21 25.92
Salmonella species 2 1.09 0 -
Providencia species 2 1.09 1 1.23
Proteus species 1 0.55 2 2.46
Citrobacter species 1 0.55 2 2.46
Pseudomonas species 0 - 3 3.70
Total 166 91.20 74 91.35
Protozoa
(observed by 
microscopy)
Giardia lamblia 11 6.04 4 4.93
Entamoeba histolytica 5 2.74 3 3.70
Total 16 8.88 7 8.64
Grand total 182 100 81 100
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Table-4
INCIDENCE OF EIEC IN DIARRHOEAL STOOL SAMPLES BY PCR n= 145
The incidence of EIEC in diarrhoeal stool samples was 5.5%. 
Table-5
INCIDENCE OF EIEC AMONG E.COLI ISOLATES BY PCR n= 138
The incidence of EIEC among E.coli was 5.79%. 
Table-6
COLORIMETRIC ASSAY - APYRASE DETECTION n=145
   
 The enzyme Apyrase  detected  in  7.58% of  study group  and  none  were 
isolated from the control group.      
Table-7
AGE AND GENDER DISTRIBUTION OF EIEC POSITIVE CASES n=8
Age(years)
No. of 
positive 
cases
Male Female
No. of 
cases percentage
No. of 
cases percentage
0-1yr 1 1 12.5 - -
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1-2yrs 4 2 25 2 25
2-3yrs 2 1 12.5 1 12.5
3-4yrs 0 0 - - -
4-5yrs 1 1 12.5 - -
Total 8 5 62.5 3 37.5
     
 50% of the cases were between 1-2 years of age. The incidence of EIEC 
was 62.5% in males and 37.5% in females.
Table-8
EIEC ISOLATED FROM CHILDREN WITH DIARRHOEA AND DYSENTERY 
n=145
Diarrhoea Dysentery Two sample binomial proportion test
No. of 
cases
No. of 
EIEC 
positive by 
PCR
% No. of cases
No. of 
EIEC 
positive by 
PCR
%
133 5 3.75 12 3 25
Z=9.53
p=0.002
Significant
    
 EIEC was isolated from 3.75% of children with diarrhoea and 25% of children 
with dysentery.
Table-9
CLINICAL FEATURES OF EIEC POSITIVE CASES n=8
Sl.No Clinical features No. of Cases Percentage
1 Fever 7 87.5
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2 Abdominal cramp 6 75
3 Diarrhoea 5 62.5
4 Vomiting 3 37.5
5 Dysentery 3 37.5
       
EIEC infection presented as diarrhoea in 62.5% of the cases and as 
dysentery in 37.5% of cases. Fever was the commonest associated symptom. 
Table-10
PRESENCE OF LEUKOCYTES AND ERYTHROCYTES IN EIEC POSITIVE 
STOOL SAMPLE n=8
Symptoms No. of cases
Leukocytes Erythrocytes
positives % positives %
Diarrhoea 5 3 37.5 2 25
Dysentery 3 3 37.5 3 37.5
Total 8 6 75 5 62.5
75% of cases had leukocytes, 62.5% had erythrocytes in their stool.
                                                    
Table -11
BIO-CHEMICAL FEATURES OF EIEC n=8
       37.5% of the EIEC isolates were non-motile and non-lactose fermenters.
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Table –12
      OD VALUES AND PCR POSITIVITY IN APYRASE POSITIVE CASES 
                    An OD value of 0.3 was taken as cut-off point.
Table-13
POLYMERASE CHAIN REACTION TARGETING APY GENE (n=141)     
           5.67 % of the isolates had  apy gene. The other isolates showed 
positive Colorimetric assay were negative for PCR.
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Table-14
EVALUATION OF COLORIMETRIC ASSAY (n=141)
Colorimetric assay
Polymerase chain reaction
Positive Negative
Total
Positive 8 3 11
Negative 0 130 130
Total 8 133 141
• Sensitivity                                         -       100 %
• Specificity    -  98  %
• Positive predictive value    -  72 %
• Negative predictive value    - 100 %
• Percentage of false positive    -  2 %
• Percentage of false negative    - 0 %
• Accuracy    - 98%
• Kappa    - 0.83
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Table-15
SERENY TEST PERFORMED ON PCR POSITIVE ISOLATES (n=8)
All the isolates were positive in sereny’s test.
Table -16
ANTIMICROBIAL SUSCEPTIBILITY PATTERN (n=8)
All the isolates were sensitive to Amikacin, Cefoperazone-sulbactum 
and all were resistant to Ampicillin
S : Sensitive
I : Intermediate
R : Resistant
Table -17
ESBL AND MDR PRODUCERS/ MDR STRAINS AMONG EIEC ISOLATES 
(n=8)
Total No. of isolates
ESBL Production Multi drug resistance
No. of cases % No. of cases %
8 4 50 6 75
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50% of the isolates were ESBL producers and 75% were MDR strains
Table-18
SEROTYPING OF EIEC ISOLATES (n=8)
O Serotype No. of isolates Percentage
            O 28 3 37.5
O 124 1 12.5
O 152 1 12.5
O untypable 3 37.5
The frequently isolated serotype was O28. 
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DISCUSSION
Acute infectious diarrhoea is one of the major causes of mortality in 
children, particularly in developing countries like India.  EIEC is one of the 
significant  causes  of  diarrhoea  in  developing  countries.  Despite  its 
acknowledged status as a human pathogen,  very little  research has been 
conducted. 
The  culture  methods  used  for  the  identification  of  EIEC  from stool 
samples are relatively inefficient. Though molecular methods are rapid and 
sensitive,  they are expensive.  The other techniques like animal  study and 
tissue culture are also expensive and time consuming. Hence to overcome 
the constraints of existing tests,  a simple, sensitive and reliable diagnostic 
test, the “Colorimetric assay” was developed. This study was conducted to 
evaluate colorimetric assay as a diagnostic test  to detect EIEC from stool 
samples. The results of the study are herewith discussed.
In the present study diarrhoea was common in the age group of 1-2 
years of age followed by 2-3 years, 0-1 year, 3-4 years and 4-5 years. In the 
current  study,  there  was  a  slightly  high  proportion  of  diarrhoea  in  male 
children  than  female  children,  with  the  ratio  of  1:0.9  and  among  control 
children the ratio was 1:1, but statistical analysis by chi-square test showed 
that  the  difference  is  not  significant  (Table  1).  The  present  study  is  in 
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accordance with the study conducted by John Albert, M. et al.,49.
In  this  study,  240 bacterial  isolates  were  recovered  from 195  stool 
samples  which  include  166  strains  from study group and  74  strains  from 
control group. Out of 195 samples, protozoans were observed in 23 samples 
by  microscopic  examination.  Based  on  statistical  analysis  of  results, 
significantly higher proportions of organisms were identified in study group 
(Table 2).
In  the  present  study,  a  total  of  166  strains  were  isolated  from 
diarrhoeal stool samples, which include Escherichia coli  (75.82%), Klebsiella 
species (12.08%), Salmonella species (1.09%), Providencia species (1.09%), 
Citrobacter species (0.55%) and Proteus species (0.55%). Cysts of Protozoa 
were  identified  in  microscopic  examination  of  16  (8.83%)  cases.  Giardia 
lamblia was observed in 6.04% of cases and Entamoeba histolytica in 2.74% 
of  children  with  diarrhoea.  From  the  control  group,  74  isolates  were 
recovered,  of  which  E.coli was  isolated  in  55.55%  of  cases.  The  other 
bacterial  isolates  recovered  from  control  group  were  Klebsiella species 
(25.92%), Providencia species (1.23%), Proteus species (2.46%), Citrobacter 
species (2.46%),  and  Pseudomonas species (3.70%).  The  Giardia  lamblia 
was  observed  in  4.93%  and  Entamoeba  histolytica in  3.70%  of  cases 
(Table-3).  A  study by Iruka  N et  al.,  2000,  has  reported  E.coli in  60.3%, 
Klebsiella species in 30.5%,  Citrobacter species in 1.2%, and Salmonella in 
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0.9%  from  stool  samples45.  Giardia  lamblia was  observed  in  9.9%  of 
diarrhoeal  stool  samples  by  Eneas  De  Carvalto  Aguiar  et  al.,  200627. 
Entamoeba histolytica was observed in 0.6% of 145 children with diarrhoea 
by John Albert M et al., 199949. 
In this study, the incidence of EIEC from children with diarrhoea was 
5.5%. No EIEC was isolated from control group by colorimetric test (Table 4). 
Nadia Vieira et al., 2007 reported EIEC from 4.8 % of diarrhoeal children and 
EIEC in 1.3 % of control children67. David N Taylor et al., 1988, reported EIEC 
from 4% of  children  with  diarrhoea,  EIEC from 0.9  % of  children  without 
diarrhoea103. This is in contrary to the study by Nazek Al-Gallas et al., 2001, 
which has isolated 11.3% of EIEC from diarrhoeal samples70. These findings 
suggest that the incidence of EIEC might vary in different parts of the world. 
The statistical analysis of this study shows that with 95% confidence interval 
the incidence might fluctuate between 2.6-10.3%. In contrast to the present 
study, Nadia Vieira et al and David N Taylor et al have reported EIEC in the 
control group, indicating that there is an existence of carrier state in healthy 
individuals.
The incidence of EIEC among E.coli isolates was 5.79%. According to 
the statistical analysis the incidence might vary from 2 to 11 % (Table 5).
There was a higher incidence of EIEC in the age group of 1-2 years 
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(50%) followed by 3-4 years of age (25%). The EIEC infection was common 
among male children (62.5%) than in female children (32.5%) (Table7). This 
was similar to the study by Elisabeth prestrel et al., 2003, where the incidence 
of EIEC was higher in children in the age group of 6 months to 2 years26. A 
study by David N. Taylor et al., 1988 disagreed with the present study and 
has reported  increased rate  of  isolation  of  EIEC with  age  and peaked in 
children of 3-5 years of age103.
The present study revealed that EIEC was isolated from 3.75% of all 
cases  of  diarrhoea  and  25% of  all  cases  of  dysentery.  P  value  of  0.002 
indicates that a significantly higher percentage of dysentery is associated with 
EIEC infection than diarrhoea (Table 8). A study by David N. Taylor et al., 
1988 showed that EIEC was isolated from 4% of all diarrhoeal stool samples 
and 7% of all dysentery samples103.
In  the  present  study,  62.5%  of  patients  with  EIEC  infection  had 
diarrhoea  as  the  presenting  symptom,  37.5%  of  patients  presented  with 
dysentery, 87.5 % of patients had fever, 75 % had abdominal cramps and 37 
% had vomiting (Table 9). David N Taylor et al., 1988 observed diarrhoea as 
a presenting symptom in 58.82 %, 35.3 % of patients with EIEC infection had 
dysentery and the commonest associated symptom with EIEC diarrhoea was 
fever (90%) followed by vomiting in 47%103. The present study correlated well 
with  the  study of  Nataro  et  al.,  1981,  which  revealed  that  EIEC infection 
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presented most commonly as watery diarrhea and rarely as dysentery68. Bui 
Thi Thu Hien et al reported watery diarrhoea in 100%, fever in 100%, vomiting 
in 100% and abdominal pain in 50% cases of EIEC diarrhoea13. 
 
In this study, 75% of patients with EIEC infection had leukocytes in 
their stools and 62.5% of patients with EIEC infection had erythrocytes in their 
stools.  Only 3 children (37.5%) had dysentery,  whereas erythrocytes were 
observed in 5 (62.5%) of children with EIEC infection, which implies that the 
remaining  2  (25%)  of  them  might  have  had  occult  blood  in  their  stools 
(Table 10).  David N Taylor  et  al.,  1988 reported erythrocytes in 89% and 
leukocytes in 44% of children with EIEC infection103. A study by Echeverria et 
al  1991  showed erythrocytes  and  leukocytes  in  36% of  cases  with  EIEC 
infection25. 
In the current study, 37.5% of EIEC were lactose negative and non-
motile (Table 11). David et al., 1985, found that 35% of EIEC isolates were 
lactose negative, 91% were non-motile103. Flores Abuxapqui JJ et al reported 
that 8.33% of EIEC recovered from stool sample were lactose negative32.  A 
study by Gustavo Faundez et al., 1988, stated that 85% of EIEC were non-
motile and 35% were non-lactose fermenters39. 
Table  12  shows the  optical  density  values  and  their  PCR result  in 
positive cases.
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  In the study group, of the total stool samples tested, the Colorimetric 
assay  for  apyrase  was  positive  in  7.58%  (11)  cases.  None  of  the  stool 
samples  from  control  group  showed  positive  test  in  colorimetric  assay. 
Binomial proportion test shows that Apyrase detection was higher in study 
group than in the control group. (Table 6). At a cut-off value of 0.3, the test 
showed 97.8% specificity (Table 14), with 3 false positives that may be due to 
Providencia species  (2)  and  Proteus species  (1).  The  reasons  for  false 
positives are unknown, but PCR analysis indicated that none carried the apy 
gene (Table13). Furthermore, not all isolates of these species were positive.
A total of 141 isolates were tested for apy gene by PCR, 8 of them 
exhibited positive band and there was no false positive by PCR. With 95% 
confidence interval  detection  of  apy gene by PCR possibly  will  vary from 
2.6-10.5%  (Table  13).  Krishnan  Sankaran  et  al.,  2008  stated  that  PCR 
targeting apy gene was 100% sensitive in detecting EIEC infection55. 
The sereny test  was done on 8 PCR positive isolates and all  were 
positive  (Table  15).  This  test  proves  the  invasive  nature  of  isolates  and 
confirms EIEC.  Thus among  E.coli only Enteroinvasive  E.coli will  express 
apyrase enzyme. Sensitivity of the test was analogous with the studies by 
Flores Abuxapqui JJ et al., 199932, and Nazek Al-Gallas et al., 200770.
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Considering PCR as a gold standard test for EIEC, the sensitivity and 
specificity  of  colorimetric  assay  in  our  study  was  100%  and  97.8% 
respectively.  The percentage of false positive was 2.1% and there was no 
false negative. The accuracy of the test was 98%; this may perhaps vary from 
94-100% (Table 14).
All  the EIEC isolates were sensitive to Amikacin and Cefoperazone-
Sulbactum. 62.5% of the isolates were sensitive to Ciprofloxacin, 37.5% of 
the isolates to Cefotaxime, 12.5% isolates to Co-trimoxazole, 50% isolates to 
Gentamicin and none were sensitive to the most commonly used antibiotic 
Ampicillin (Table 16). Resistance to ≥ 3 drugs was observed in 75% of EIEC 
isolates and ESBL production was seen in 50 % of EIEC isolates (Table 17). 
The  antibiotics  Amikacin  and  Cefoperazone-Sulbactum  were  active 
against all isolates, but these can only be administered in hospital settings. 
The strains showed 75% sensitivity to Ciprofloxacin; however Ciprofloxacin 
and other quinolones are not approved for children. All the isolates showed 
100% resistance to Ampicillin and 87.5% to Co-trimoxazole. This could be 
due to the reality that,  most of  the cases admitted in the wards could be 
refractory to treatment, since this is a tertiary care hospital. However results 
of  the  current  study  might  not  be  statistically  significant,  because,  lesser 
number of EIEC isolates were analyzed. 
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The study by Teresa Estrada et al., 2005 on antimicrobial susceptibility 
pattern  of  EIEC  revealed  resistance  of  50%  to  ampicillin  and  all  were 
sensitive to co-trimoxazole. 50% of the isolates showed multi drug resistance 
i.e. resistance to Ampicillin, co-trimoxazole and chloramphenicol104.
In the present study, frequently isolated serotype was O28 (37.5 %). 
12.5 % of the isolates belonged to O124, 12.5 % to O152 and 37.5 % were 
untypable  (Table  18).  O28ac  (25  %),  O124  (25  %)  were  the  frequently 
isolated serotypes in the study conducted by Gustavo Faundez et al., 198839. 
Prats G et al., quoted that O124 was the most frequently isolated serotype.80
.
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SUMMARY
 Totally 195 children 0-5 years of age with diarrhoea and without diarrhoea 
were included in the study.
 This study was done to evaluate colorimetric assay as a diagnostic test to 
detect EIEC.
 Colorimetric  assay  and  PCR were  done  for  all  the  samples  to  detect 
Apyrase enzyme and apy gene respectively, which are specific for EIEC.
 Incidence of EIEC in children with diarrhoea was 5.5 %.
 EIEC infection presented most commonly as diarrhoea (75%) and rarely 
as  dysentery  (25%).  The  commonest  associated  symptom  was  fever 
followed by abdominal pain and vomiting.
 Incidence of  EIEC infection  was higher  in  the 1-2 years  of  age (50%) 
followed by in 2-3 years of age (25%).
 There was preponderance of EIEC infection in males (62.5%).
 Majority of the EIEC isolates were lactose positive (75%).
 Out of  145 samples tested, colorimetric assay for the enzyme Apyrase 
was positive in 7.58 % cases of diarrhoea. Colorimetric assay had 100 % 
sensitivity  and  97.8%  specificity.  This  test  overcomes  many  of  the 
constraints of standard available methods like expensive equipment, need 
for  well  trained hands, cost  of  maintenance of the animals and limited 
availability in developing countries. Hence, the excellent sensitivity of this 
test can be made use of in diagnosing pathogenic strains of EIEC from 
diarrhoeal stool samples. 
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 PCR for apy gene was positive in 5.5% of cases.
 Colorimetric assay correlated well with the Sereny’s test. 
 All  the  EIEC  isolates  were  sensitive  to  Amikacin  and  Cefoperazone-
Sulbactum  and  all  were  resistant  to  Ampicillin.  The  isolates  showed 
variable  resistance  to  Ciprofloxacin  (12.5%),  Co-trimoxazole  (75%), 
Gentamicin (50%). 75% of the isolates showed multidrug resistance.
 50 % of the EIEC isolates were ESBL producer.
 O28 was the frequently isolated serotype.
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CONCLUSION
Incidence  of  EIEC in  children  with  diarrhoea  was  5.5%.  Evaluation  of 
colorimetric assay shows that this can be adopted as a diagnostic test  to 
detect  Apyrase  enzyme of  EIEC from stool  samples.  Besides  this  test  is 
simple, less expensive and results can be obtained earlier, to start antibiotics 
promptly. Therefore further complications can be prevented. PCR targeting 
apy gene is more specific for diagnosing EIEC infection. Antibiogram should 
be done for all dysentery cases, since most of the strains showed multidrug 
resistance (75%) and ESBL production (50%). Amikacin and Cefoperazone-
Sulbactum  are  recommended  for  severe  cases  of  diarrhoea.  O28  was 
frequently isolated serotype.
Any disease for  that matter  “      ”Prevention is always better than Cure . 
This can be achieved by promotion of  exclusive breast  feeding,  improved 
water sanitation and promotion of personal and environmental hygiene. 
60
BIBLIOGRAPHY
1) Adam, T., M. Arpin, M.-C. Pre´vost, P. Gounon, and P. J. Sansonetti.  1995. 
Cytoskeletal rearrangements and the functional role of T-plastin during entry 
of Shigella flexneri into HeLa cells. J. Cell Biol. 129:367–381.
2) Allaoui, A., P. J. Sansonetti, R. Me´nard, S. Barzu, J. Mounier, A. Phalipon, 
and C.  Parsot.  1995.  MxiG,  a  membrane protein required for  secretion of 
Shigella  spp.  Ipa invasins:  involvement in  entry into  epithelial  cells and in 
intercellular dissemination. Mol. Microbiol. 17:461–470.
3) Andrews, G. P., A. E. Hromockyj, C. Coker, and A. T. Maurelli.  1991. Two 
novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion 
of invasion plasmid antigens. Infect. Immun. 59:1997–2005.
4) Anjaiah B clinical paediatrics 2nd edn. Paras publisher 2003.ch 76.pp 442.
5) Babu,  M.M.  Kamalakannan,  S.,  Subrahmanyam,  Y.U.B.K.  & Sankaran,  K. 
(2002)  shigella  apyrase –  a  novel  variant  of  bacterial  acid  phosphatases 
FEBS Lett 512, 8-12.
6) Baudry, B., A. T. Maurelli, P. Clerc, J. C. Sadoff, and P. J. Sansonetti. 1987. 
Localization of plasmid loci necessary for the entry of  Shigella flexneri  into 
HeLa cells,  and characterization  of  one locus encoding  four  immunogenic 
polypeptides. J. Gen. Microbiol. 133:3403–3413.
7) Bauer, A.W., W. M. N Kirby, J. C. Sherris, and M. Turk. 1966. Antimicrobial  
susceptibility testing by a standardized single disk method. Am.  Clin. Pathol.  
45: 493-496.
8) Berlutti, F. et al 1998. Expression of the virulence plasmid carried apyrase 
gene  (apy)  of  Enteroinvasive  Escherichia coli and  Shigella flexneri is under 
the control of H-NS and the Vir F and Vir B regulatory cascade Infect Immun 
66, 4957 – 4964.
9) Bernardini  ML,  Mounier  J,  D’  Hauteville  H et  al.,  Identification of  ics  A,  a 
plasmid locus that governs intra- and intercellular spread through interaction 
with F- actin. Proc Natl Acad Sci USA.1989; 86:3867-3871.
10)  Bertin L et al., Origin and characteristics of EIEC isolated from Germany. 
Epidemiology of infect. 1997 Jun; 118 (3): 199-205.
11)  Bhargava,  T.,  Datta,  S.,  Ramakrishnan,  V.  Roy,  R.K.  Sankaran, 
K&Subramanyam,  Y.V.B.K.  (1995).  Virulent  Shigella codes  for  absolute 
apyrase.  Identification,  Characterization  and  cloning  of  the  gene.  Curr 
Science 68, 293-300.
12)  Birnboim H and J Doly 1979.  A rapid extraction procedure for  screening 
recombinant plasmid DNA Nucleic acids. Res 7: 1513-1525.
13)  Bui  Thi  Thu  Hien,  Flemming  Scheutz,  Phung  Dac  Cam,  Oralak 
Serichantalergs, Diarrheagenic Escherichia coli  and Shigella Strains Isolated 
from Children in a Hospital Case-Control Study in Hanoi, Vietnam_Journal of 
Clinical Microbiology, Mar. 2008, p. 996–1004 Vol. 46, No. 3
14)  Cave H et al., 1994, Differentiation of E.coli strains using randomly amplified 
polymorphic DNA analysis.
15) Chaudhary  U,  Aggarwal  R  Extended  spectrum  β-Lactamases  –  An 
emerging threat to clinical therapeutics.  Ind Journ Of Med Microbiol.2004: 
22:2:p 75-80
16) Chinen  I,  Rivas  M,  Caffer  MI,  Cinto  RO,  Binsztein  N.  Diagnosis  of  
Enteroinvasive Escherichia  coli  associated  with  diarrhoea.  Rev  Argent  
Microbiol 1993, 25 (1) 27-35.
17) Clinical  Laboratory  Standard  Institute.  Performance  standard  for  
Antimicrobial Disc Susceptibility Tests.Vol1 Jan 2006.
18) Clude  persot. Shigella and EIEC pathogenicity factors. FEMS Microbiology 
letters, Vol 252, Issue 1, Nov 2005. p 11-18.
19) Crichton PB, Old DC, 1985,  Biotyping of  Escherichia coli:  methods and 
applications,  The  Virulence  of  E.coli,  ed.  Sussman  M,  Academic  Press, 
London, 315-32.
20)  Day N.  P.,  S.  M.  Scotland and B.  Rowe. Comparison of  a  Hep-2 tissue 
culture test with sereny test for detection of Enteroinvasiveness in  Shigella 
species and E.coli. J clin Micro. 1981, 3: 596-597.
21)  Day  WA,  Maurelli  AT.  Shigella and Enteroinvasive Escherichia  Coli; 
Paradigms  for  pathogen  evolution  and  host  parasite  interactions.  In. 
Donnenberg MS Ed.  E. coli:  virulence mechanism of a versatile pathogen. 
San Diego: Academic Press; 2002:209-237.
22)  Du  Pont  HL:  Guidelines  on  acute  infectious  disease  in  adults  Am  J 
Gastroenterology 92: 1962, 1997.
23)  DuPont HL, FormalSB, Hornick RB, Snyder MJ, Libonati JP, and prevention 
and treatment of gastroenteritis. Curr. Opin. Infect. Dis. 5:66–73. 1971
24)  Durno,  C.,  R.  Soni,  and P. Sherman.  1989.  Adherence of vero cytotoxin 
producing  Escherichia coli  serotype O157:H7 to isolated epithelial cells and 
brush border membranes in vitro: role of type 1 fimbriae (pili) as a bacterial 
adhesin expressed by strain CL-49. Clin. Invest. Med. 12:194–200.
25)  Echeverria  P,  Sthabutr  O,  Pitarangsi  C.  Microbiology  and  diagnosis  of 
infections with  Shigella  and Enteroinvasive E.coli.  Rev Infect Dis 1991 Mar-
Apr; 13 Supple 4: S220-5
26)  Elisabeth  Presterl  et  al.,  Frequency  and  virulence  properties  of 
diarrhoeagenic E.coli in children with diarrhoea in Gabon. Am J of Trop Med 
Hyg.m 60(4) 2003, pp. 406-410.
27)  Eneas de Carvalto naguiar et al., 2006. Rev. Inst. Med. Trop. S. Paulo Vol.49 
no3. Sao Paulo may/ June 20
28)  Escolar  L,  Perez  –  martin  J,  De  Lorenzo  V.  Opening  the  iron  box: 
Transcriptional  metalloregulation by the  fur  protein.  J  Bacteriol 1999;  181: 
6223-6229.
29)  Ewing WH, 1986, The genus Escherichia; the genus Shigella, Edwards and 
Ewings identification of Enterobacteriaceae, 4th edition, Elsevier, New York, 
Amsterdam, Oxford, 93-134, 135-72.
30)  Falkow S.  Molecular  Koch’s  postulates applied  to  microbial  pathogenicity 
Rev Infect Dis 1988; 10 (Supple 2): S 274 – S276.
31)  Farmer  III  JJ,  1995,  Enterobacteriaceae:  introduction  and  identification, 
Manual  of  clinical  Microbiology,  6th edn,  eds  Murray PR,  Baron EJ et  al., 
American Society for Microbiology, Washington, DC, 438-49
32)  Flores  Abuxapqui  JJ  et  al.,  Four  bio-chemical  tests  for  identification  of 
probable EIEC strains. Rev Latino am Microbiol 1999. 41(4); 259-61
33)  Forfur and Arneil’s Textbook of pediatrics. Ed Neil McIntosh, Peter Holms 
and Rosalind Smyth. 6th edn. Rp 2004. p 679- 681.
34)  Frankel, G., J. A. Giron, J. Vlamossoi, and G. Schoolnik. 1989. Multi-gene 
amplification: simultaneous detection of three virulence genes in diarrhoeal 
stool. Mol. Microbiol. 3:1729–1734.
35)  Galan  JE,  collmer  A.  Type  III  Secretion  Machines:  Bacterial  devices  for 
protein delivery into host cells science. 1999; 284: 1322 – 1328.
36)  Goldberg, M. B., O. Baˆrzu, C. Parsot, and P. J. Sansonetti. 1993. Unipolar 
localization and ATPase activity of IcsA, a Shigella flexneri protein involved in 
intracellular movement. J. Bacteriol. 175:2189–2196.
37)  Gomes, T. A. T., R. F. Toledo, L. R. Trabulsi, P. K. Wood, and J. G. Morris. 
1987. DNA probes for identification of Enteroinvasive Escherichia coli. J. Clin. 
Microbiol. 25:2025–2027.
38)  Gordillo, M. E., G. R. Reeve, J. Pappas, J. J. Mathewson, H. L. DuPont, and 
Murray B.E.,.  1992.  Molecular characterization of  strains of  Enteroinvasive 
Escherichia coli  O143, including isolates from a large outbreak in Houston, 
Texas. J. Clin. Microbiol. 30:889–893.
39)  Gustavo  Faundez  et  al.,  Characterization  of  EIEC  strains  isolated  from 
children with diarrhea in Chile. J of Clin Microbiol, 1988, 928-932.
40)  Harris, J. R., J. Mariano, J. G. Wells, B. S. Payne, H. D. Donnel, and M. L. 
Cohen. 1985. Person-to-person transmission in an outbreak of Enteroinvasive 
Escherichia coli. Am. J. Epidemiology. 122:245–252.
41)  Harrison’s Principles of Internal Medicine. Kaspe, Braudwald, Fauci, Hauser 
longo Jamson.16th edn. (1) 2005. 754-759, 878-885,902-906 225
42) Hart  CA, Batt  RM, Saunders JR. Diarrhoea caused by  E.coli .Ann Trop 
Paediatr H 1993; 13 (2): 121-31.
43)  Holmes B, Gross RJ, 1990, Coliform bacteria; various other members of the 
Enterobacteriaceae, Topley and Wilson’s principles of Bacteriology, Virology 
and  Immunology,  8th edition,  eds  parker  MT,  Collier  LH,  Edward  Arnold, 
London, 415-41.
44)  Holt  JG,  Krieg  NR  et  al.,  1994,  Bergey’s  Manual  of  Determinative 
Bacteriology, 9th edition, Williams & Wilkins, Baltimore, 179-80, 187-8.
45)  Iruka N Okeke, Adebayo Lamikandra et al., Characterization of E.coli strains 
from cases of childhood diarrhea in provincial southwestern Nigeria. J of Clin 
Microbiol, Jan 2000, p. 7-12.
46)  Isberg RR. Discrimination between intracellular uptake and surface adhesion 
of bacterial pathogens. Science. 1991; 252: 934-938.
47)  Ishikawa, K. et al., 2000, X-Ray structures of novel acid phosphatases from 
Escherichia blattae and its complex with the transition state analog melybdate 
EMBOJ 9, 21412-2423.
48)  Jann K,  Jann B,  1987,  Polysaccharide antigens of  Escherichia  coli,  Rev 
Infect Dis 9, supple. 5. S5517-26.
49)  John Albert,  A.S.G Faruque,  S.M.  Faruque et  al.,  Case control  study of 
Enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J 
of Clin Microbiol, Nov. 1999, p. 3458-3464.
50)  Kamalakkannan,  V.  Murugan,  M.V.  Jagannadham,  R.Nagaraj  and 
K.Sankaran  Bacterial  lipid  modification  of  proteins  for  novel  protein 
engineering applications. Protein Eng Des & sel Vol 17. 10pp. 721-729, 2004.
51)  Kauffmann F, 1944, Zur Serologic der coli-  gruppe.  Acta Pathol Microbiol  
Scand, 21: 20-45.
52) Ketyi  I,   epidemiology  of  the  Enteroinvasive  E.coli.  Observations  in 
Hungery. J Hyg. Epidemiology. Microbiol Immunol. 1989; 33 (3): 261-7.
53)  Komoszynki, M., and Wojtezak 1996. Apyrase (ATP dihydrophosphotase, EC 
3.6.1.5):  function  and  relationship  with  ATPase.  Biochem.  Biophys.  Acta 
1310:233-241.
54)  Konemann’s Color Atlas and Textbook of Diagnostic Microbiology. 6th edn. 
Lippincott Williams & Wilkins. Enterobacteriaceae 211-302.
55)  Krishnan Sankaran, Sanchari Banerjee, Asalapuram R. Pavan kumar et al., 
Apyrase based colorimetric assay for detection of Shigella and Enteroinvasive 
Escherichia  coli in  stool.  Diagnostic  Microbiology  and  Infectious  Disease. 
Accepted on October 2008. Article in Press.
56)  Lanyi,  B.,  J.  Szita,  A.  Ringelhann,  and  K.  Kovach.  1959.  A  waterborne 
outbreak  of  enteritis  associated  with  Escherichia  coli  serotype  124:72:32. 
Acta. Microbiol. Hung. 6:77–78.
57)  Lawn  AM,  Orskov  I,  Orskov  F,  1977,  Morphological  distinction  between 
different H serotypes of E.coli, J Gen Microbiol, 101:111-119.
58)  Luscher  D,  Altwegg M,  1994,  Detection of  Shigellae,  Enteroinvasive and 
Enterotoxigenic E.coli using  the  Ploymerase  chain  reaction  in  patients 
returning from tropical countries, Mol cell probes, 8: 285-90.
59) Mackie and McCartney Practical Medical Microbiology 14th edn. Editors J.  
Gerald Collee, Barrie P. Marmion, Andrew G. Fraser, Anthony Simmons. Ch  
20. Enterobacteriaceae 361-384.
60)  Malabi Venkatesan et al., Development and testing of invasion associated 
DNA  probes  for  detection  of  Shigella  species and.  J.  Clin.  Micro 1998, 
261-266.
61)  Mandell,  Douglas  and  Bennett’s  Principles  and  Practice  of  infectious 
diseases.5th edn. Vol I
62)  Mantis  N  et  al.,  1996,  Analysis  of  epithelial  cell  stress  response  during 
infection by Shigella flexneri.  Infect. Immun 64: 2774-2482.
63)  Marier, R., J. G. Wells, R. C. Swanson, W. Dallhan, and I. J. Mehlman. 1973. 
An outbreak of Enteropathogenic Escherichia coli  food borne disease traced 
to imported French cheese. Lancet ii: 1376–1378.
64)  Maurelli,  A.  T.  1994.  Virulence protein export  systems in  Salmonella  and 
Shigella: a new family or lost relatives. Trends Cell Biol. 4:240–242. 
65)  Menard, R., P. J. Sansonetti, and C. Parsot. 1993. No polar mutagenesis of 
the  ipa  genes defines ipaB, ipaC, and ipaD as effectors of  Shigella flexneri  
entry into epithelial cells. J. Bacteriol. 175:5899–5906.
66)  Menard, R., M. C. Pre´vost, P. Gounon, P. Sansonetti, and C. Dehio. 1996. 
The secreted Ipa complex of Shigella flexneri promotes entry into mammalian 
cells. Proc. Natl. Acad. Sci. USA 93:1254–1258
67)  Nadia Vieira et al.,  High prevalence of Enteroinvasive E.coli isolated in a 
remote region of northern coastal Ecuador. Am J Trop Med Hyg 73(3), 2007, 
528-533.
68) Nataro* James P,  and james b.  kaper.  Diarrhoeagenic  Escherichia  coli.  
Clinical  microbiology  reviews,  Jan.  1998,  p.  142–201  vol.  11,  no.  1998,  
American society for microbiology. 
69) National  Committee  for  Clinical  Laboratory  Standards.  M100-S13.  
Performance  standards  for  antimicrobial  susceptibility  testing;  Thirteenth  
informational supplement. NCCLS 2003. Wayne, USA. 
70)  Nazek Al-Gallas et al .Etiology of acute diarrhoea in children and adults in 
Tunis, Tunisia, with emphasis on diarrhoeagenic Escherichia coli: prevalence, 
phenotyping and molecular epidemiology.  Am. J.  Trop. Med.  Hyg.,  77 (3), 
2007, 571-582.
71)  Nelson Textbook of Paediatrics. Robert M. Kliegman, Hal B. Jensen, Richard 
E.  Behrman Bonita  F.  Stanton (ed)  18th edn.2008.  Vol  I  Ch196 & 197.  P 
1191-1196.
72)  Nikaido  H.  Outer  membrane  In:  Neidhardt  FC,  ed.  Escherichia  coli and 
Salmonella: cellular  and  molecular  biology.  Washington,  DC:  ASM  Press, 
1996: 29-47.
73)  Oliver DB Periplasm In: Neidhardt FC, ed. Escherichia Coli and Salmonella 
Cellular and molecular biology, Washington, DC: ASM Press 1996: 88-103.
74)  Orskov F, Orskov I.1977. Escherichia Coli Serotyping and disease in man 
and animals Can. J. of M. Microbiol 1992; 38: 699-674.
75)  Orskov F and Orskov I  1984 serotyping  of  Escherichia  Coli,  Methods in 
Microbiology, Vol. 14, ed. Bergan T, Academic Press, London, 43-112..
76) Pal T, Emody L, Pacsa AS. ELISA detectable virulence marker antigen of  
EIEC is coded by a 140 Md plasmid.  Acta Microbiol Hung. 1986; 33 (4):  
341-4.
77)  Parashur  U,  Umesh,  Bresee  JS,  Josephs,  Glass  Rt,  Roger).  The  global 
burden  of  diarrhoeal  disease  in  children,  Bulletin  of  World  Health 
Organization 2003, 81 (4); 236.
78)  Park JT. The murein saccular. In : Neidhardt FC, ed. Escherichia Coli and 
Salmonella;  cellular  and  molecular  Biology,  Washington  DC  ASM  Press; 
1996: 48-57
79)  Peng J, Yang J, Jin Q.The molecular evolutionary history of  Shigella spp. 
and Enteroinvasive  Escherichia coli. Infect Genet Evol 2008 Oct 19. [Epub 
ahead of print].
80) Prats  G,  Llovet  T.  EIEC. Pathogenesis  and epidemiology.  Microbiologic  
1995. March: 11 (1): 916.
81) Pupo  GM,  Lan  R,  Reeves  PR,  2000.  Multiple  independent  origins  of  
Shigella  clones  of  E.coli and  convergent  evolution  of  many  of  their  
characteristics. Proc Natl Acad Sci USA 97: 10567-10572.
82)  Raetg RH Bacterial  lipopolysaccharides: A remarkable family of  bioactive 
macroamphiphiles.  In:  Neidhardt FC, ed.  Escherichia Coli and  Salmonella:  
Cellular  and  molecular  biology,  Washington,  DC:  ASM  press;  1996: 
1035-1063.
83)  Raj P. Pathogenesis and laboratory diagnosis of Escherichia coli-associated 
enteritis. Clin Microbiol Newsletter. 1993; 15: 89-93.
84)  Rohner P et al., Etiological agents of infectious diarrhoea: Implications for 
requests for microbiol culture. J Clin Microbiol 35: 1427, 1997.
85)  Rossolini, G.M. et al., 1998. Bacterial nonspecific acid phosphohydrolases: 
physiology, evolution and use as tools in microbial biotechnology cell mol life.  
Sci 54, 833-850.
86)  Rowe B, Gram RJ, 1984, Genus II, Shigella Castellani and Chalmers 1919, 
Bergey’s  Manual  of  Systemic Bacteriology,  Vol.  1,  eds.  Krieg  N,  Holt  JG, 
Williams & Wilkins, Baltimore and London , 423-7.
87) Sabrina J Moyo, Samwel Y Maselle et al. Identification of diarrhoeagenic 
Escherichia  coli isolated  from  infants  and  children  in  Dar  es  Salaam, 
Tanzania. BMC Infectious diseases 2007, 7:92 1186/1471-2334-7-92.
88)  Salyer AA, Whitt DD, 1994, Bacterial pathogenesis: a molecular Approach, 
1st edn, ASM press, Washington DC.
89)  Sansonetti,  P.  J.  Molecular  and  cellular  biology  of  Shigella  flexneri  
invasiveness:  from cell  assay systems to  shigellosis.  Curr.  Top.  Microbiol.  
Immunol. 1992. 180:1–19.
90)  Sansonetti,  PJ.  Rupture,  invasion  and  inflammatory  destruction  of  the 
intestinal barrier by Shigella, making sense of prokaryote- eukaryote cross 
talk. FEMS Microbiol Rev. 2001; 25:3-14.
91)  Santapaola, D., et al., 2002 Enteroinvasive Escherichia coli virulence plasmid 
carried apyrase (apy) and osp B genes are organized as a bicistronic operon 
and are subject to differential expression. Microbiology 148, 2519-2529.
92)  Santapola  et  al.,  2006  Apyrase,  the  product  of  the  virulence  plasmid 
Encoded Pho N1 (apy) Gene of Shigella flexneri,  IS Necessary for proper 
unipelar ICS A localization and for efficient intracellular. Spread Am society of 
microbiology
93) Sasakawa C et al., Virulence associated genetic regions comprising 31 Kbs 
of  the  230  kb  plasmid  in  Shigella  flexneri  2a.  J  Bacteriol 1988;  170: 
2480-2484)
94)  Serena sarli, Mauro Nicoletti, Serena schippa, Federica Del Chierico, aniela 
Santapaola et al., Ala 160 and His 116 residues are involved in activity and 
specificity of Apyrase, an ATP hydrolyzing enzyme produced by EIEC. Mirco. 
151 (2005), 2853-2860
95)  Sereny B, 1956. Experimental keratoconjunctivitis Shigellosa. Acta Microbiol.  
Acad. Science Hung.4: 367-377.
96)  Sethabutr O Venkatesan M et al., 1993, Detection of Shigella and Entero 
invasive E.coli by  amplification  of  the  invasive  plasmid  antigen  H  NDA 
sequence in patients with dysentery. J Infectious Dis, 167: 458-61.
97)  Shanta Dutta  et  al.,  2001 Sensitivity and performance  characteristics  of 
direct PCR with stool samples in comparison to conventional techniques for 
the diagnosis of Shigella and EIEC infection in children with acute diarrhea in 
Calcutta, India. J Med Micro 50: 667-674.
98)  Sheahan  DG,  LaBree  EH,  Kolas  JP,  1971.Pathogenesis  of  E.coli 
diarrhea. N Engl J Med 285:1-9.)
99)  Silverman M, and Simon  MI 1977, Bacterial flagella, Ann Rev Microbiol, 31: 
397-419.
100)Snyder,  J.  D.,  J.  G.  Wells,  J.  Yashuk,  N.  Puhr,  and  P.  A.  Blake.  1984. 
Outbreak of invasive Escherichia coli gastroenteritis on a cruise ship. Am. J.  
Trop. Med. Hyg. 33:281–284.
101)Sujata  Bhattacharya,  Basudev  Bhattacharya  studies  on  Siderophore 
production of different diarrhoeagenic Escherichia coli.  J Indian Med Assoc. 
2007; 105: 110-8.
102)Szakal  D.  Pal.T  Comparison  of  media  for  the  selective  culture  of 
Enteroinvasive E.coli. Eur J Clin Micro Infect Dis 2003, 22:235-241.
103)Taylor, D. N., P. Echeverria, O. Sethabutr, C. Pitarangi, U. Leksomboon, N. 
R.  Blacklow,  B.  Rowe,  R.  Gross,  and  J.  Cross.  1988.  Clinical  and 
microbiologic  features  of  Shigella  and  enteroinvasive  Escherichia  coli  
infections detected by DNA hybridization. J. Clin. Microbiol. 26:1362–1366.
104)Theresa Estrada-Garcia et al., Drug resistant Diarrhoeagenic E.coli, Mexico. 
Em. Inf. Dis vol II, No: 8, 2005; 1306-1308.
105)Topley  and  Wilson  Microbiology  and  Microbial  infections,  10th edition,  M 
Altioegg  and  J  Bockemuhl:  Escherichia  Coli and  Shigella  Chapter  40. 
936-965.
106)Tulloch, E. F., K. J. Ryan, S. B. Formal, and F. A. Franklin.  1973. Invasive 
enteropathic Escherichia coli dysentery. Ann. Intern. Med. 79:13–17.
107)Vasselon, T., J. Mounier, R. Hellio, and P. J. Sansonetti.  1992. Movement 
along actin filaments of the perijunctional area and de novo polymerization of 
cellular actin is required for Shigella flexneri colonization of epithelial Caco-2 
cell monolayers. Infect. Immun. 60:1031–1040.
108)Venkatesan,  M.  M.,  J.  M.  Buysse,  and  E.  V.  Oaks.  1992.  Surface 
presentation  of  Shigella  flexneri  invasion  plasmid  antigens  requires  the 
products of the spa locus. J. Bacteriol. 174:1990–2001.
109)WHO 1985. Treatment and Prevention of acute diarrhea and guidelines for 
the trainees of health workers, Geneva WHO.
110)WHO  1999,  Health  situation  in  the  South-East  Asia  Region  1994-1997, 
Regional Office of SEAR, New Delhi.
111)WHO 2006, Weekly epidemiological Record No.6, 10th Feb., 2006.
APPENDIX I
Mac Conkey agar
Peptone 20g
Sodium taurocholate 5g
Agar 20g
Neutral red solution, 2% in 50% ethanol 3.5g
Lactose, 10 % aqueous solution 100ml
Dissolve the peptone and taurocholate in the water by heating. Add the 
agar  and  dissolve  it  in  the  steamer  or  autoclave.  If  necessary,  clear  by 
filtration. Adjust the pH 7.5.
Xylose lysine deoxycholate agar
Yeast extract    3g
Xylose 3.75g
Lactose 7.5g
Sucrose 7.5g
L-Lysine 5.0g
Sodium Chloride 5.0g
Sodium deoxycholate 2.5g
Sodium thiosulphate 6.8g
Ferric ammonium citrate 0.8g
Phenol red 0.08g
Agar 15 g
Water 1 Litre
   Except for the deoxycholate, thiosulphate and ferric ammonium citrate, 
dissolve the ingredients in the water by autoclaving. Cool to 50˚c and add 20ml of 
a solution of sodium thiosulphate 34% and ferric ammonium citrate 4%, and 25 
ml of a solution of sodium deoxycholate 10 %. Adjust the pH to 7.4.
Selenite F broth
Sodium hydrogen selenite 4 g
Peptone 5 g
Lactose 4 g
Disodium hydrogen phosphate        9.5 g
Sodium dihydrogen phosphate        0.5 g
Sterile water           1 litre
 All the ingredients were dissolved in sterile water with sterile precautions. 
The  yellow  solution  in  about  10ml  amounts  distributed  into  screw  capped 
universal bottles. Steamed for 20 minutes at 100˚c. Adjust pH to 7.1. 
Mueller- Hinton Agar:
  Beef extract              20 gm
  Acidicase peptone 7.5 gm
  Starch 1.5 gm
  Agar 17 gm
  Distilled water 1000 ml
                The ingredients were dissolved in one liter of distilled water, mixed 
thoroughly. Heated with frequent agitation and boiled for 1 minute. pH adjusted to 
7.4. Sterilized by autoclaving and poured in plates.
APPENDIX II
 Catalase
3 % hydrogen peroxide
Oxidase reagent
        1% Tetra methyl para- phanelyne diamino dihydrochloride  
Kovac’s reagent
Para-dimethyl amino benzaldehyde 10gm
Iso-amyl alcohol 150 ml
Concentrated – Hydrochloric Acid 80 ml
Triple Sugar Iron
Peptone 2 gm
Sodium Chloride 0.5gm
Yeast Extract 0.3gm
Beef Extract 0.3gm
Glucose 0.1gm
Lactose 1.0gm
Sucrose 0.2gm
Ferric Citrate 0.03gm
Sodium thiosulphate 0.03gm
Sodium Chloride 0.5 gm
Phenol Red 0.2% Solution 1.2ml
Distilled Water 100 ml
pH 7.4
    Heat to dissolve the solids. Add the indicator solution. Mix and sterilize at 
121˚C for 15 minutes and cool to form slopes with deep (3cm)butts.
Simmons citrate agar
Ammonium dihydrogen phosphate            
Potassium dihydrogen phosphate
0.1gm
0.1gm
Sodium chloride 
Sodium citrate
Magnesium sulphate            - 
Bromothymol blue 0.2%
Agar 
Distilled water 
pH
0.5gm
0.5gm
0.02gm
4ml
2gm
100 ml
6.8
         Dispense and autoclave at 121˚c for 15 minutes and allow cooling to form 
slopes.
 Christensen’s urea agar
Peptone
Glucose 10% solution
Sodium chloride
Dipotassium hydrogen phosphate  
Agar
Distilled water
0.1gm
1ml
0.5gm
0.2gm
2gm
100ml
               Sterilize the glucose and urea solution by filtration.Prepare the basal 
medium without glucose or urea, adjust to pH 6.8-6.9 and sterilize by autoclaving 
in a flask at 121˚c for 30 minutes. Cool to about 50˚c, add glucose, urea and 
form slopes with deep
APPENDIX III
 REAGENTS REQUIRED FOR THE COLORIMETRIC ASSAY
WASH REAGENT
Saline-CaCl2: 0.9% NaCl containing 1mM CaCl2
ASSAY REAGENT
Assay Buffer: 40mM EDTA, pH 7.5
1.5g of Di sodium EDTA is dissolved in 80 ml of phosphate-free distilled water. 
This is a stable reagent.
 
Substrate Solution: 6mM Sodium Pyrophosphate
1.6 mg of Sodium Pyrophosphate decahydrate is dissolved in 1ml of phosphate-
free distilled water.
 Just  before  assay,  mix  equal  volumes of  Assay Buffer  and substrate 
solution to give the final reagent, which is 3mM Sodium Pyrophosphate in 20mM 
EDTA, pH 7.5.
COLOR REAGENT
Reagent A: 5% Acidic Ammonium Molybdate
 5 g of Ammonium Molybdate is dissolved gradually in 10N H2SO4.
Reagent B: 1% Ferrous Ammonium sulphate (FAS)
1 gram of FAS is weighed and dissolved in 10 ml of phosphate free distilled 
water.
 
LURIA BERTANI BROTH
Sodium Chloride : 10g
Tryptone : 10g
Yeast Extract : 5gm
Distilled Water : 1 Litre
pH : 7.2
The  ingredients  were  dissolved  in  one  liter  of  distilled  water,  mixed 
thoroughly. Heated with frequent agitation and boiled for 1 minute. pH adjusted to 
7.4. Sterilized by autoclaving and poured in plates.

